Long-term survival of a woman with peritoneal mesothelioma
Author Information
Author(s): Pillai Krishna, Akhter Javed, Pourgholami Mohammad H, Morris David L
Primary Institution: Department of Surgery, St. George Hospital, University of New South Wales, Kogarah, NSW, Australia
Hypothesis
The expression of estrogen receptor β in malignant mesothelioma leads to tumor suppression and a better prognosis.
Conclusion
The patient's long survival may be due to minimal disease, complete cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, and the positivity of estrogen receptor β in the tumor.
Supporting Evidence
- The patient had a low disease volume with no metastasis.
- She underwent complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
- Immunohistochemical examination showed high expression of estrogen receptor β.
Takeaway
A woman with a rare cancer called peritoneal mesothelioma lived for seven years after treatment because her disease was not very aggressive and she received special surgery and chemotherapy.
Methodology
The patient underwent cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
A 48-year-old Caucasian woman.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website